Unresectable Hepatocellular Carcinoma (HCC)

Unresectable Hepatocellular Carcinoma (HCC) is the indication for 8 drugs in DrugBank. It is covered by 15 curated, structured indications.

Also known as: Unresectable Hepatocellular Carcinoma
Classified under: Digestive System Diseases
Neoplasms
Indicated drugs: Atezolizumab
Bevacizumab
Durvalumab
Ipilimumab
Lenvatinib
Nivolumab
Sorafenib
Tremelimumab

What you can answer from here — as of September 26, 2026

8Indicated drugsWith each drug's targets and mechanism

Listed above

15Structured indicationsPopulation, line of therapy, route and combination as fields, not prose

72Clinical trialsPhase, status and sponsor resolved per trial

2Drugs reporting it as an adverse effectWith incidence where the label states it

Which approved drugs for Unresectable Hepatocellular Carcinoma (HCC) share a target, and which companies have late-stage candidates against it?

Create a free account or log in to explore the full data card.